HPC
CELG

HM Payson & Co’s Celgene Corp CELG Stock Holding History

HM Payson & Co’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-9,090
Closed -$903K – 999
2019
Q3 		$903K Buy
9,090
+75
+0.8% +$7.13K 0.03% 208
2019
Q2 		$833K Buy
+9,015
New +$856K 0.03% 215
2019
Q1 		– Sell
-1,384
Closed -$89K – 287
2018
Q4 		$89K Sell
1,384
-8,117
-85% -$599K 0.26% 71
2018
Q3 		$850K Buy
9,501
+5,452
+135% +$482K 0.04% 189
2018
Q2 		$321K Buy
+4,049
New +$336K 0.01% 269
2018
Q1 		– Sell
-109,574
Closed -$11.4M – 360
2017
Q4 		$11.4M Buy
109,574
+36,969
+51% +$4.17M 0.46% 55
2017
Q3 		$10.6M Buy
72,605
+69,008
+1,918% +$9.4M 0.46% 58
2017
Q2 		$467K Sell
3,597
-250
-6% -$30.6K 0.02% 239
2017
Q1 		$479K Buy
3,847
+140
+4% +$16.8K 0.02% 230
2016
Q4 		$429K Buy
3,707
+200
+6% +$22.3K 0.02% 232
2016
Q3 		$366K Sell
3,507
-315
-8% -$34.1K 0.02% 238
2016
Q2 		$377K Sell
3,822
-261
-6% -$27K 0.02% 233
2016
Q1 		$409K Buy
4,083
+126
+3% +$13K 0.02% 224
2015
Q4 		$474K Buy
3,957
+1,825
+86% +$211K 0.02% 218
2015
Q3 		$231K Hold
2,132
– – 0.01% 271
2015
Q2 		$247K Sell
2,132
-255
-11% -$29.2K 0.01% 273
2015
Q1 		$275K Buy
2,387
+240
+11% +$28.7K 0.01% 261
2014
Q4 		$240K Buy
+2,147
New +$226K 0.01% 278

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

HM Payson & Co's CELG Position: Q4 2019 in Review

HM Payson & Co sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 9,090 shares — an estimated $903K sold.

HM Payson & Co first reported a position in CELG in Q4 2014 and held it in 18 quarters. The position peaked at $11.4M in Q4 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • HM Payson & Co reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • HM Payson & Co sold 9,090 Celgene Corp shares in Q4 2019, an estimated $903K.
  • HM Payson & Co first reported a position in Celgene Corp in Q4 2014 and held it in 18 quarters.
  • HM Payson & Co's Celgene Corp position peaked at $11.4M in Q4 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on HM Payson & Co's 13F filing for Q4 2019, filed 18 Feb 2020.